Search research articles
Contact Us
Filters
Showing results (11-20 of 170) with videos related to
Page
of 17
Sort By:
Advances in Neurobiology
|
September 29, 2017
From Age-Related Cognitive Decline to Alzheimer's Disease: A Translational Overview of the Potential Role for Phosphodiesterases
Pim R A Heckman, Arjan Blokland, Jos Prickaerts
Behavioural Brain Research
|
July 19, 2014
Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia
Stoyo Karamihalev, Jos Prickaerts, Nick P van Goethem
Neuroscience and Biobehavioral Reviews
|
February 12, 2020
Role of cyclic nucleotides and their downstream signaling cascades in memory function: Being at the right time at the right spot
Elentina K Argyrousi, Pim R A Heckman, Jos Prickaerts
European Journal of Pharmacology
|
April 1, 2015
The use of EEG parameters as predictors of drug effects on cognition
Arjan Blokland, Jos Prickaerts, Marlies van Duinen, et al.
Physiology & Behavior
|
September 5, 2003
Assessment of spatial learning abilities of mice in a new circular maze
Guido Koopmans, Arjan Blokland, Petra van Nieuwenhuijzen, et al.
Progress in Brain Research
|
September 6, 2008
The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease
Kimmo A Michelsen, Jos Prickaerts, Harry W M Steinbusch
Behavioural Brain Research
|
December 9, 2003
Performance of different mouse strains in an object recognition task
Ayhan Sik, Petra van Nieuwehuyzen, Jos Prickaerts, et al.
Frontiers in Neurology
|
October 18, 2016
Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine
Arjan Blokland, Anke Sambeth, Jos Prickaerts, et al.
Trials
|
March 4, 2024
A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial
Nina Possemis, Frans Verhey, Jos Prickaerts, et al.
Behavioural Brain Research
|
April 7, 2012
Object recognition testing: statistical considerations
Sven Akkerman, Jos Prickaerts, Harry W M Steinbusch, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 170) with videos related to
Sort By:
Page
of 17
Advances in Neurobiology
|
September 29, 2017
From Age-Related Cognitive Decline to Alzheimer's Disease: A Translational Overview of the Potential Role for Phosphodiesterases
Pim R A Heckman, Arjan Blokland, Jos Prickaerts
Behavioural Brain Research
|
July 19, 2014
Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia
Stoyo Karamihalev, Jos Prickaerts, Nick P van Goethem
Neuroscience and Biobehavioral Reviews
|
February 12, 2020
Role of cyclic nucleotides and their downstream signaling cascades in memory function: Being at the right time at the right spot
Elentina K Argyrousi, Pim R A Heckman, Jos Prickaerts
European Journal of Pharmacology
|
April 1, 2015
The use of EEG parameters as predictors of drug effects on cognition
Arjan Blokland, Jos Prickaerts, Marlies van Duinen, et al.
Physiology & Behavior
|
September 5, 2003
Assessment of spatial learning abilities of mice in a new circular maze
Guido Koopmans, Arjan Blokland, Petra van Nieuwenhuijzen, et al.
Progress in Brain Research
|
September 6, 2008
The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease
Kimmo A Michelsen, Jos Prickaerts, Harry W M Steinbusch
Behavioural Brain Research
|
December 9, 2003
Performance of different mouse strains in an object recognition task
Ayhan Sik, Petra van Nieuwehuyzen, Jos Prickaerts, et al.
Frontiers in Neurology
|
October 18, 2016
Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine
Arjan Blokland, Anke Sambeth, Jos Prickaerts, et al.
Trials
|
March 4, 2024
A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial
Nina Possemis, Frans Verhey, Jos Prickaerts, et al.
Behavioural Brain Research
|
April 7, 2012
Object recognition testing: statistical considerations
Sven Akkerman, Jos Prickaerts, Harry W M Steinbusch, et al.
Page
of 17